QQ客服 官方微博 反馈留言

	Clinical metabolic analysis combined with traceability of biosynthetic pathway:a new approach to quality marker of Chinese materia medica
	Zhi-Rui Yang[1]; Ai-Ting Wang[1]; Juan Liu[1,2,3]; Xin-Yu Yang[1]; Xiao-Fang Wang[1]; Lei Zhang[1]; Na Guo[4]; Jia-Chen Zi[5]; Cheng Peng[6]; Shu-Xun Yan[7]
	2019
卷号	2期号:1页码:3-10
关键词	中药 质量标志物 临床代谢分析 生源合成 金芪降糖片 2型糖尿病
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4709911
专题	成都中医药大学
作者单位	1.[1]Beijing Shijitan Hospital,Capital Medical University,Beijing,China 2.[2]Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use,Beijing,China 3.[3]International Cooperation&Joint Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use,Beijing,China 4.[4]Experimental Research Center,China Academy of Chinese Medical Sciences,Beijing,China 5.[5]JiNan University,Guangzhou,China 6.[6]Chengdu University of Traditional Chinese Medicine,Chengdu,China 7.[7]The first affiliated hospital,Henan University of China Medicine,Zhengzhou,China
推荐引用方式 GB/T 7714	Zhi-Rui Yang[1],Ai-Ting Wang[1],Juan Liu[1,2,3],et al. Clinical metabolic analysis combined with traceability of biosynthetic pathway:a new approach to quality marker of Chinese materia medica[J],2019,2(1):3-10.
APA	Zhi-Rui Yang[1].,Ai-Ting Wang[1].,Juan Liu[1,2,3].,Xin-Yu Yang[1].,Xiao-Fang Wang[1].,...&Dan Yan[1,2,3].(2019).Clinical metabolic analysis combined with traceability of biosynthetic pathway:a new approach to quality marker of Chinese materia medica.,2(1),3-10.
MLA	Zhi-Rui Yang[1],et al."Clinical metabolic analysis combined with traceability of biosynthetic pathway:a new approach to quality marker of Chinese materia medica".2.1(2019):3-10.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。